The CRISPR Journal is a new peer-reviewed publication from Mary Ann Liebert started in February of 2018. The journal delivers groundbreaking multidisciplinary research, advances, and commentary on CRISPR. Areas of coverage for the journal include:
- CRISPR biology and technology
- Host-pathogen interactions
- Microbial immunity
- Genetic diseases
- Gene therapy
- Cancer immunotherapy
- Embryonic development
- Bioinformatics
- Systems biology
- CRISPR-Cas evolution
- Animal models
- Organ transplantation
- Bioethics
- IP and patenting
The CRISPR Journal provides a home for original research papers, as well as review articles, perspectives, profiles, and commentary. Authors interested in submitting should consult their Information for Authors page.